By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Lovastatin

Lovastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|614 words

What is Lovastatin?

Lovastatin is a prescription medication belonging to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels in the blood and reduce the risk of cardiovascular disease. Lovastatin was one of the first statins developed and remains an important treatment option for managing high cholesterol and preventing heart attacks and strokes.

Uses

Lovastatin is prescribed for several cardiovascular conditions:

  • High cholesterol (hypercholesterolemia): Reduces elevated total cholesterol and LDL (“bad”) cholesterol levels while modestly increasing HDL (“good”) cholesterol
  • Primary prevention of cardiovascular disease: Helps prevent heart attacks and strokes in people with risk factors but no existing heart disease
  • Secondary prevention after cardiovascular events: Reduces the risk of repeat heart attacks, strokes, and other cardiovascular complications in patients with existing heart disease
  • Mixed dyslipidemia: Treats conditions involving multiple abnormal lipid levels, including elevated triglycerides
  • Familial hypercholesterolemia: Manages inherited conditions that cause severely elevated cholesterol levels

How it works

Lovastatin works by inhibiting HMG-CoA reductase, a key enzyme in the liver responsible for producing cholesterol. By blocking this enzyme, lovastatin reduces the liver’s ability to manufacture cholesterol, forcing the liver to remove more cholesterol from the bloodstream to meet its needs. This mechanism effectively lowers blood cholesterol levels and has additional benefits for blood vessel health and inflammation reduction.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Muscle pain or weakness
  • Headache
  • Digestive issues (nausea, diarrhea, constipation)
  • Dizziness
  • Skin rash
  • Fatigue
  • Sleep disturbances
  • Joint pain

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, tenderness, or weakness (signs of rhabdomyolysis)
  • Dark-colored urine or decreased urination
  • Yellowing of skin or eyes (signs of liver problems)
  • Unexplained persistent muscle pain with fever
  • Memory problems or confusion

Warnings and precautions

  • Liver function monitoring: Regular liver enzyme tests are recommended, especially during the first year of treatment, as lovastatin can rarely cause liver damage
  • Muscle toxicity risk: Patients should report unexplained muscle pain, particularly when combined with certain other medications that increase risk
  • Pregnancy and breastfeeding: Lovastatin is contraindicated during pregnancy and breastfeeding due to potential harm to fetal development
  • Kidney disease: Dosage adjustments may be necessary for patients with severe kidney impairment
  • Age considerations: Elderly patients may be more susceptible to muscle-related side effects and require closer monitoring

Interactions

Lovastatin has several important drug interactions that can increase the risk of serious side effects:

  • Gemfibrozil and other fibrates: Significantly increases risk of muscle toxicity and rhabdomyolysis
  • Cyclosporine: Immunosuppressive drug that dramatically increases lovastatin blood levels
  • Macrolide antibiotics (erythromycin, clarithromycin): Can increase lovastatin concentration and muscle toxicity risk
  • Antifungal medications (itraconazole, ketoconazole): Inhibit lovastatin metabolism, leading to increased drug levels
  • Warfarin: Lovastatin may enhance anticoagulant effects, requiring closer monitoring of bleeding risk
  • Grapefruit juice: Large amounts can increase lovastatin levels and side effect risk
  • Niacin (high doses): Combination may increase muscle toxicity risk
  • Protease inhibitors: HIV medications that can significantly increase lovastatin blood levels

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing for lovastatin ranges from 20 mg to 80 mg taken once daily with the evening meal. Most patients start with 20 mg daily, with dosage adjustments made based on cholesterol response and tolerance. The maximum recommended dose is 80 mg daily, though this higher dose is reserved for patients requiring significant cholesterol reduction who have not achieved goals with lower doses. Lovastatin should be taken with food to improve absorption. Dosage should always be determined and monitored by a healthcare provider based on individual patient factors, cholesterol levels, and treatment response.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Lovastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/lovastatin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Rosuvastatin

By
GMJ News Desk
01/06/2026

Simvastatin

By
GMJ News Desk
01/06/2026

Atorvastatin

By
GMJ News Desk
01/06/2026

Pravastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up